ATE111746T1 - Polymyxinkonjugate. - Google Patents

Polymyxinkonjugate.

Info

Publication number
ATE111746T1
ATE111746T1 AT90810872T AT90810872T ATE111746T1 AT E111746 T1 ATE111746 T1 AT E111746T1 AT 90810872 T AT90810872 T AT 90810872T AT 90810872 T AT90810872 T AT 90810872T AT E111746 T1 ATE111746 T1 AT E111746T1
Authority
AT
Austria
Prior art keywords
polymyxin
conjugates
polymyxin conjugates
bloodstream
potent
Prior art date
Application number
AT90810872T
Other languages
English (en)
Inventor
Dean Allen Handley
Philip Lake
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Application granted granted Critical
Publication of ATE111746T1 publication Critical patent/ATE111746T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
AT90810872T 1989-11-15 1990-11-13 Polymyxinkonjugate. ATE111746T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43748789A 1989-11-15 1989-11-15

Publications (1)

Publication Number Publication Date
ATE111746T1 true ATE111746T1 (de) 1994-10-15

Family

ID=23736660

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90810872T ATE111746T1 (de) 1989-11-15 1990-11-13 Polymyxinkonjugate.

Country Status (17)

Country Link
EP (1) EP0428486B1 (de)
JP (1) JPH082917B2 (de)
KR (1) KR0184858B1 (de)
AT (1) ATE111746T1 (de)
AU (1) AU639952B2 (de)
CA (1) CA2029997A1 (de)
CY (1) CY2052B1 (de)
DE (1) DE69012747T2 (de)
DK (1) DK0428486T3 (de)
ES (1) ES2063326T3 (de)
HK (1) HK49696A (de)
HU (1) HU210901A9 (de)
IE (1) IE65268B1 (de)
IL (1) IL96326A (de)
MY (1) MY104520A (de)
NZ (1) NZ236050A (de)
ZA (1) ZA909187B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5545721A (en) * 1992-12-21 1996-08-13 Ophidian Pharmaceuticals, Inc. Conjugates for the prevention and treatment of sepsis
US6579696B1 (en) * 1992-12-21 2003-06-17 Promega Corporation Polymyxin B conjugates
US6660267B1 (en) 1992-12-21 2003-12-09 Promega Corporation Prevention and treatment of sepsis
WO1994014437A1 (en) * 1992-12-21 1994-07-07 Ophidian Pharmaceuticals, Inc. Prevention and treatment of sepsis
US6180134B1 (en) 1993-03-23 2001-01-30 Sequus Pharmaceuticals, Inc. Enhanced ciruclation effector composition and method
DE69433341T2 (de) * 1993-09-22 2004-04-15 Henry M. Jackson Foundation For The Advancement Of Military Medicine Verfahren zur aktivierung von löslichem kohlenhydraten durch verwendung von neuen cyanylierungsreagenzien, zur herstellung von immunogenischen konstrukten
US5849301A (en) * 1993-09-22 1998-12-15 Henry M. Jackson Foundation For The Advancement Of Military Medicine Producing immunogenic constructs using soluable carbohydrates activated via organic cyanylating reagents
JP2581425B2 (ja) * 1993-11-12 1997-02-12 株式会社島津製作所 ペプチド合成用支持体及びそれを用いて製造されたペプチド
ATE241384T1 (de) * 1995-03-22 2003-06-15 Jackson H M Found Military Med Herstellung von immunogenen konstrukten unter verwendung von löslichen kohlehydraten, die durch organische cyanylierungs-reagenzien aktiviert wurden
DE122009000055I1 (de) * 1995-03-22 2009-12-31 Jackson H M Found Military Med Herstellung von immunogenen konstrukten unter verwendung von löslichen kohlehydraten, die durch organische cyanylierungs-reagenzien aktiviert wurden
US5691304A (en) * 1995-05-25 1997-11-25 Novartis Ag Improved process for preparing polymyxin B/dextran conjugates
US6309646B1 (en) 1996-05-09 2001-10-30 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Protein-polysaccharide conjugate vaccines and other immunological reagents prepared using homobifunctional and heterobifunctional vinylsulfones, and processes for preparing the conjugates
US5998381A (en) * 1996-12-06 1999-12-07 Ophidian Pharmaceuticals, Inc. Compounds that bind bacterial pili
IT1312110B1 (it) 1999-05-18 2002-04-04 Istituto Biochimico Pavese Pha Addotti antibiotico-polimero polisaccaridico naturale
DE10129369C1 (de) * 2001-06-21 2003-03-06 Fresenius Kabi De Gmbh Wasserlösliches, einen Aminozucker aufweisendes Antibiotikum in Form eines Pol ysaccharid-Konjugats
AT507846B1 (de) * 2009-01-22 2011-12-15 Fresenius Medical Care De Gmbh Sorptionsmittel für endotoxine
KR102433278B1 (ko) * 2014-10-03 2022-08-16 셀리아 파마슈티칼즈 에이피에스 조성물
US20190328833A1 (en) * 2016-10-21 2019-10-31 Algipharma As Polymyxin-alginate oligomer conjugates

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7702261L (sv) * 1976-03-02 1977-09-07 Pharmaco Inc Forfarande for att immobilisera antimikrobiella emnen
JPS5813519A (ja) * 1981-07-16 1983-01-26 Seikagaku Kogyo Co Ltd エンドトキシン吸着材及びそれを用いるエンドトキシンの除去方法
US4496689A (en) * 1983-12-27 1985-01-29 Miles Laboratories, Inc. Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer

Also Published As

Publication number Publication date
HU210901A9 (en) 1995-09-28
AU639952B2 (en) 1993-08-12
IL96326A0 (en) 1991-08-16
CY2052B1 (en) 1998-04-30
IE904105A1 (en) 1991-05-22
MY104520A (en) 1994-04-30
JPH03220198A (ja) 1991-09-27
IE65268B1 (en) 1995-10-18
DK0428486T3 (da) 1995-01-09
KR910009274A (ko) 1991-06-28
EP0428486B1 (de) 1994-09-21
ES2063326T3 (es) 1995-01-01
KR0184858B1 (ko) 1999-05-01
EP0428486A1 (de) 1991-05-22
ZA909187B (en) 1992-07-29
HK49696A (en) 1996-03-29
DE69012747T2 (de) 1995-03-16
NZ236050A (en) 1993-04-28
CA2029997A1 (en) 1991-05-16
DE69012747D1 (de) 1994-10-27
AU6655590A (en) 1991-05-23
IL96326A (en) 1995-07-31
JPH082917B2 (ja) 1996-01-17

Similar Documents

Publication Publication Date Title
DE69012747D1 (de) Polymyxinkonjugate.
EP0537299A4 (de) Disulfidkonjugate von oligonukleotid-transportagenten.
EP0364509A4 (de) Zellulare toxische konjugate.
FI956019L (fi) Eristettyjä peptidejä, jotka muodostavat komplekseja MHC-molekyyli HLA-C-klooni-10:n kanssa, ja niiden käyttö
DE69004426D1 (de) Gassackzusammenbau.
FI906083A7 (fi) Foerbaettringar i cyklopeptidderivat och beroerande dessa.
NO910656D0 (no) Sperrevaeske-tetningsanordning for turbokompressor.
DK0555361T3 (da) Pulverformige farvepræparater og fremgangsmåde til fremstilling deraf
FI915821L (fi) Skaftprotes.
DE69007311D1 (de) Konjugate.
FI901988A0 (fi) Koncentrerad, glutaraldehyd och 1,2-benzisotiazolin-3-on innehaollande, vattenhaltig loesning och dess anvaendning.
ITTO910567A0 (it) Derivati carbostirilici.
FI915956A0 (fi) Automatiserad floedes rotameter.
DE69104883D1 (de) Operationstische.
NO890453L (no) Artropodicide preparater.
NO910655L (no) Sperrevaeske-tetningsanordning for turbokompressor.
ES2104752T3 (es) Materiales dentales a base de (met)acrilatos.
DE69109424D1 (de) Turbovakuumpumpe.
NO894594D0 (no) Farmasoeytiske sammensetninger omfattende labdan diterpenoid-derivater og pyrimido(6,1-a)isoquinolin-4-ono-derivater.
SE9200599L (sv) Hållaranordning för ett arbetsredskap, speciellt skördemaskin
DE69006704D1 (de) Trifunktionelle Polyoxyethylenediaminderivate.
DE69114727D1 (de) Gassack.
NO900731D0 (no) Boelgelengde-spesifikke cytotoksiske midler.
FR2667148B1 (fr) Balance postale.
ES1015285Y (es) Sillita plegable de juguete.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee